ACTIONABILITY KNOWLEDGE REPOSITORY ACTIONABILITY CURATION INTERFACE
Update History
Syndrome: Familial thoracic aortic aneurysms and dissections (FTAAD)
Gene/Gene Panel: FBN1, TGFBR1, TGFBR2, SMAD3, ACTA2, MYLK, MYH11
Context: Adult
Date
Status
Outcomes-Interventions
Notes
2022/01/14
Released (Under revision)
1.1.4
Aortic dilation progression (GroupA)
Pharmacotherapy (GroupA) 10CB
Clinically significant aortic aneurysm (GroupA)
Aortic surveillance (GroupA) 11CC
Assertions
Gene Disease Pairs
Suggested Assertion
Final Assertion
ACTA2 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6
Strong Actionability
Strong Actionability
FBN1 0019625 MARFAN SYNDROME; MFS
Strong Actionability
Strong Actionability
LOX 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10
Strong Actionability
Strong Actionability
MYH11 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4
Strong Actionability
Strong Actionability
PRKG1 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8
Strong Actionability
Strong Actionability
SMAD3 0019625 LOEYS-DIETZ SYNDROME 3; LDS3
Strong Actionability
Strong Actionability
TGFB2 0019625 LOEYS-DIETZ SYNDROME 4; LDS4
Strong Actionability
Strong Actionability
TGFBR1 0019625 LOEYS-DIETZ SYNDROME 1; LDS1
Strong Actionability
Strong Actionability
TGFBR2 0019625 LOEYS-DIETZ SYNDROME 2; LDS2
Strong Actionability
Strong Actionability
2021/08/16
Released
1.1.4
Aortic dilation progression (GroupA)
Pharmacotherapy (GroupA) 10CB
Clinically significant aortic aneurysm (GroupA)
Aortic surveillance (GroupA) 11CC
Assertions
Gene Disease Pairs
Suggested Assertion
Final Assertion
ACTA2 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6
Strong Actionability
Strong Actionability
FBN1 0019625 MARFAN SYNDROME; MFS
Strong Actionability
Strong Actionability
LOX 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10
Strong Actionability
Strong Actionability
MYH11 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4
Strong Actionability
Strong Actionability
PRKG1 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8
Strong Actionability
Strong Actionability
SMAD3 0019625 LOEYS-DIETZ SYNDROME 3; LDS3
Strong Actionability
Strong Actionability
TGFB2 0019625 LOEYS-DIETZ SYNDROME 4; LDS4
Strong Actionability
Strong Actionability
TGFBR1 0019625 LOEYS-DIETZ SYNDROME 1; LDS1
Strong Actionability
Strong Actionability
TGFBR2 0019625 LOEYS-DIETZ SYNDROME 2; LDS2
Strong Actionability
Strong Actionability
2021/08/16
Released (Under revision)
1.1.3
Aortic dilation progression (GroupA)
Pharmacotherapy (GroupA) 10CB
Clinically significant aortic aneurysm (GroupA)
Aortic surveillance (GroupA) 11CC
Assertions
Gene Disease Pairs
Suggested Assertion
Final Assertion
ACTA2 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6
Strong Actionability
Strong Actionability
FBN1 0019625 MARFAN SYNDROME; MFS
Strong Actionability
Strong Actionability
LOX 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10
Strong Actionability
Strong Actionability
MYH11 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4
Strong Actionability
Strong Actionability
PRKG1 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8
Strong Actionability
Strong Actionability
SMAD3 0019625 LOEYS-DIETZ SYNDROME 3; LDS3
Strong Actionability
Strong Actionability
TGFB2 0019625 LOEYS-DIETZ SYNDROME 4; LDS4
Strong Actionability
Strong Actionability
TGFBR1 0019625 LOEYS-DIETZ SYNDROME 1; LDS1
Strong Actionability
Strong Actionability
TGFBR2 0019625 LOEYS-DIETZ SYNDROME 2; LDS2
Strong Actionability
Strong Actionability
2021/08/16
Released
1.1.3
Aortic dilation progression (GroupA)
Pharmacotherapy (GroupA) 10CB
Clinically significant aortic aneurysm (GroupA)
Aortic surveillance (GroupA) 11CC
Assertions
Gene Disease Pairs
Suggested Assertion
Final Assertion
ACTA2 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 6; AAT6
Strong Actionability
Strong Actionability
FBN1 0019625 MARFAN SYNDROME; MFS
Strong Actionability
Strong Actionability
LOX 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 10; AAT10
Strong Actionability
Strong Actionability
MYH11 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 4; AAT4
Strong Actionability
Strong Actionability
PRKG1 0019625 AORTIC ANEURYSM, FAMILIAL THORACIC 8; AAT8
Strong Actionability
Strong Actionability
SMAD3 0019625 LOEYS-DIETZ SYNDROME 3; LDS3
Strong Actionability
Strong Actionability
TGFB2 0019625 LOEYS-DIETZ SYNDROME 4; LDS4
Strong Actionability
Strong Actionability
TGFBR1 0019625 LOEYS-DIETZ SYNDROME 1; LDS1
Strong Actionability
Strong Actionability
TGFBR2 0019625 LOEYS-DIETZ SYNDROME 2; LDS2
Strong Actionability
Strong Actionability
2021/08/02
Released (Under revision)
1.1.2
Aortic dilation progression (GroupA)
Pharmacotherapy (GroupA) 10CB
Clinically significant aortic aneurysm (GroupA)
Aortic surveillance (GroupA) 11CC
MONDO IDs added, scoring groups unadjusted.
2020/12/23
Released
1.1.2
Aortic dilation progression (GroupA)
Pharmacotherapy (GroupA) 10CB
Clinically significant aortic aneurysm (GroupA)
Aortic surveillance (GroupA) 11CC
MONDO IDs added, scoring groups unadjusted.
2019/10/03
Released (Under revision)
1.1.1
Aortic dilation progression
Pharmacotherapy 10CB
Clinically significant aortic aneurysm
Aortic surveillance 11CC
2019/09/16
Released
1.1.1
Aortic dilation progression
Pharmacotherapy 10CB
Clinically significant aortic aneurysm
Aortic surveillance 11CC
2019/07/15
Released (Under revision)
1.1.0
Aortic dilation progression
Beta blockers 11DC
Clinically significant aortic aneurysm
Aortic surveillance 11DC
Internal system migration related to merging adult and pediatric contexts.
2019/04/04
Released
1.1.0
Aortic dilation progression
Beta blockers 11DC
Clinically significant aortic aneurysm
Aortic surveillance 11DC
Internal system migration related to merging adult and pediatric contexts.
2018/11/01
Released
1.0.2
Aortic dilation progression
Beta blockers 11DC
Clinically significant aortic aneurysm
Aortic surveillance 11DC
Internal system migration related to score text replacement from E to N
2018/01/11
Released
1.0.1
Aortic dilation progression
Beta blockers 11DC
Clinically significant aortic aneurysm
Aortic surveillance 11DC
2017/10/23
Released
1.0.0
Aortic dilation progression
Beta blockers 11DC
Clinically significant aortic aneurysm
Aortic surveillance 11DC
¤ Powered by BCM's Genboree.